Real-world survival outcomes and treatment patterns in patients (pts) with unresectable hepatocellular carcinoma (uHCC): Results from the OREIOS study.

Authors

null

Stephen Chan

Department of Clinical Oncology, Prince of Wales Hospital, The Chinese University of Hong Kong, Hong Kong, China

Stephen Chan , Valeriy Vladimirovich Breder , Yu Yun Shao , David Tai , Imam Waked , Sandip Ganguly , Ashwaq Alolayan , Ahmed Aboutaleb , Heba Farag , Min-Hee Ryu

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2024 ASCO Gastrointestinal Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session B: Cancers of the Pancreas, Small Bowel, and Hepatobiliary Tract

Track

Pancreatic Cancer,Hepatobiliary Cancer,Neuroendocrine/Carcinoid,Small Bowel Cancer

Sub Track

Patient-Reported Outcomes and Real-World Evidence

Clinical Trial Registration Number

NCT05239507

Citation

J Clin Oncol 42, 2024 (suppl 3; abstr 449)

DOI

10.1200/JCO.2024.42.3_suppl.449

Abstract #

449

Poster Bd #

A14

Abstract Disclosures

Similar Posters

First Author: Masafumi Ikeda

Poster

2023 ASCO Gastrointestinal Cancers Symposium

Real world data of systemic therapy for hepatocellular carcinoma in Japan: HERITAGE study.

Real world data of systemic therapy for hepatocellular carcinoma in Japan: HERITAGE study.

First Author: Yoshinari Asaoka